Sechi G - Search Results

1

The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Balbi P, Salvini S, Fundarò C, Frazzitta G, Maestri R, Mosah D, Uggetti C, Sechi G. Balbi P, et al. Among authors: sechi g. J Neurol. 2010 Dec;257(12):1955-62. doi: 10.1007/s00415-010-5706-1. Epub 2010 Aug 20. J Neurol. 2010. PMID: 20721574 Review.

2

Correspondence regarding: Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.

Sechi G, Balbi P, Bachetti T, Ceccherini I. Sechi G, et al. J Neuropathol Exp Neurol. 2010 Dec;69(12):1270; author reply 1270-1. doi: 10.1097/NEN.0b013e3181fe9e86. J Neuropathol Exp Neurol. 2010. PMID: 21107140 No abstract available.

3

Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up.

Sechi G, Ceccherini I, Bachetti T, Deiana GA, Sechi E, Balbi P. Sechi G, et al. Among authors: sechi e. JIMD Rep. 2013;9:67-71. doi: 10.1007/8904_2012_180. Epub 2012 Oct 13. JIMD Rep. 2013. PMID: 23430549 Free PMC article.

4

Beneficial effects of curcumin on GFAP filament organization and down-regulation of GFAP expression in an in vitro model of Alexander disease.

Bachetti T, Di Zanni E, Balbi P, Ravazzolo R, Sechi G, Ceccherini I. Bachetti T, et al. Among authors: sechi g. Exp Cell Res. 2012 Sep 10;318(15):1844-54. doi: 10.1016/j.yexcr.2012.06.008. Epub 2012 Jun 15. Exp Cell Res. 2012. PMID: 22705585

5

Ceftriaxone has a therapeutic role in Alexander disease.

Sechi G, Matta M, Deiana GA, Balbi P, Bachetti T, Di Zanni E, Ceccherini I, Serra A. Sechi G, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):416-7. doi: 10.1016/j.pnpbp.2009.11.021. Epub 2009 Nov 27. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19948199 No abstract available.

6

In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation.

Bachetti T, Di Zanni E, Balbi P, Bocca P, Prigione I, Deiana GA, Rezzani A, Ceccherini I, Sechi G. Bachetti T, et al. Among authors: sechi g. Exp Cell Res. 2010 Aug 1;316(13):2152-65. doi: 10.1016/j.yexcr.2010.05.005. Epub 2010 May 21. Exp Cell Res. 2010. PMID: 20471977

7

Safe drugs to fight mutant protein overload and alpha-1-antitrypsin deficiency.

Sechi G, Balbi P, Bachetti T, Ceccherini I. Sechi G, et al. J Hepatol. 2011 Oct;55(4):949-50. doi: 10.1016/j.jhep.2011.03.033. Epub 2011 Jun 12. J Hepatol. 2011. PMID: 21708201 Free article. No abstract available.

8

Clinicopathologic features of folate-deficiency neuropathy.

Sechi G, Fois C, Addis A, Sechi E. Sechi G, et al. Among authors: sechi e. Neurology. 2015 Sep 22;85(12):1090-1. doi: 10.1212/01.wnl.0000471972.90236.b6. Neurology. 2015. PMID: 26391416 No abstract available.

9

Letter re: Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

Sechi G, Demurtas R, Boadu W, Ortu E. Sechi G, et al. Neurology. 2017 Oct 24;89(17):1842. doi: 10.1212/WNL.0000000000004566. Neurology. 2017. PMID: 29061676 No abstract available.

10

Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia.

Fancellu L, Borsini W, Romani I, Pirisi A, Deiana GA, Sechi E, Doneddu PE, Rassu AL, Demurtas R, Scarabotto A, Cassini P, Arbustini E, Sechi G. Fancellu L, et al. Among authors: sechi g, sechi e. BMC Neurol. 2015 Dec 12;15:256. doi: 10.1186/s12883-015-0513-z. BMC Neurol. 2015. PMID: 26652600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page